They play roles in collagen synthesis, cellular regeneration, and reducing inflammation
Read the full study: Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for People with Type 2 Diabetes (Lancet 2023)
Oral supplementation short-term: A systematic review and meta-analysis of oral alpha-lipoic acid for diabetic neuropathy found that doses of 600 to 1,800 mg daily taken for 3 to 5 weeks modestly improved symptoms of peripheral neuropathy compared to placebo, reducing symptoms such as burning, pain, numbness, and prickling of the feet and legs, as well as improving sensation
2014: Dulaglutide (Trulicity) is approved by the FDA, and is recognized as the first type 2 diabetes drug to reduce the risk of major adverse cardiovascular events (MACE)
Recent research suggests both methods work better than regular oral supplements to help with age-related NAD+ decline
If you're interested in optimizing muscle growth, recovery, and metabolic health, understanding timing is essential